Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease

Overview of attention for article published in Alzheimer's Research & Therapy, January 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 1 news outlet
twitter: 2 tweeters

patent: 1 patent

Citations

dimensions_citation: 111 Dimensions

Readers on

mendeley: 141 Mendeley

Summary News Twitter Patents Dimensions citations

So far, Altmetric has seen 2 news stories from 1 outlets.

Maladie d'Alzheimer : pourquoi ce nouveau traitement suscite autant d'inquiétude que d'espoir

National Geographic, 13 Jan 2023

Jusqu’à récemment, malgré des décennies de recherche intensives, aucun médicament capable de faire reculer la maladie d’Alzheimer…

Alzheimer’s drug FDA approval spurs optimism—and some caution

National Geographic, 11 Jan 2023

Science Lecanemab targets what some see as the underlying cause of Alzheimer’s, but reports of deaths associated with the…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.